| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-08 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-08 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-07 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-07 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
9e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |